CDR is inviting comments and feedback on new initiatives ‘proposed to facilitate earlier access to drugs without compromising the high quality of CDR reviews.’
Indirect evidence: indirect treatment comparisons in meta-analysis.
Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyneuropathy.
Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis.
Portable ultrasonography in small emergency departments: a systematic review of the guidelines and clinical-effectiveness.
Using Canadian administrative databases to derive economic data for health technology assessments.
[links to external webpages]